Author's posts listings
Three longtime allies have joined forces to create the new Penn Medicine/CHOP Friedreich’s Ataxia Center of Excellence.
Permanent link to this article: http://www.research.chop.edu/blog/3-25-million-gift-creates-penn-medicinechop-friedreichs-ataxia-center-excellence/
The list of genes affecting blood pressure is expanding, as researchers pursue likely targets for therapeutics already in existence or in development.
Permanent link to this article: http://www.research.chop.edu/blog/new-gene-signals-likely-blood-pressure-drug-targets/
In an example of how many CHOP researchers’ work isn’t confined to the laboratory, Children’s Hospital Neuroscientist Akiva S. Cohen, PhD, recently traveled to Washington, DC to discuss concussion treatment strategies and to advocate for increased federal support for concussion research.
Permanent link to this article: http://www.research.chop.edu/blog/chop-neuroscientist-advocates-federal-concussion-support/
Pediatric palliative care is a powerful intervention that can be prescribed alongside curative or life-prolonging therapies for children with serious illnesses.
Permanent link to this article: http://www.research.chop.edu/blog/campaign-raises-awareness-pediatric-palliative-care/
Biomedical research advocates had hoped that a surge in research and development funding in the 2014 budget would be the best medicine for the National Institutes of Health, which has been impaired by mandated across-the-board sequestration cuts.
Permanent link to this article: http://www.research.chop.edu/blog/research-advocates-dispirited-omnibus-funding-level-nih/
The Children’s Hospital of Philadelphia Research Institute’s chief scientific officer, Philip R. Johnson, MD, is among the co-authors of a new study that presents an advanced approach to vaccine design.
Permanent link to this article: http://www.research.chop.edu/blog/chop-research-leader-contributes-study-showing-new-approach-vaccines-dangerous-viruses/
Most of us have heard of the “good cholesterol” and “bad cholesterol” coursing through our bloodstream. In the conventional wisdom of the past 30 years, having more of the “good” variety — high-density lipoprotein, or HDL — can lower your risk of heart disease, while more “bad” cholesterol — low-density lipoprotein, or LDL — increases your risk.
Permanent link to this article: http://www.research.chop.edu/blog/study-leads-increased-heart-disease-risk-understanding/
One in every 691 babies in the U.S. is born with Down syndrome, according to the National Down Syndrome Society, and have a predisposition for a certain kind of cancer.
Permanent link to this article: http://www.research.chop.edu/blog/alexs-lemonade-stand-foundation-grant-supports-chop-childhood-cancer-research-project/
The Children’s Hospital of Philadelphia’s Ethan Goldberg, MD, PhD, recently received an award from the epilepsy advocacy organization Citizens United for Research in Epilepsy (CURE) to study using transplanted cells to treat epilepsy.
Permanent link to this article: http://www.research.chop.edu/blog/neurologist-receives-award-study-cell-based-epilepsy-treatment/
Along with its research partners Drexel University and Hebrew University of Jerusalem, The Children’s Hospital of Philadelphia Research Institute recently hosted a collaborative research symposium that gave researchers from all three institutions the chance to connect and share ideas.
Permanent link to this article: http://www.research.chop.edu/blog/collaborations-set-advance-healthcare-children/